What is Cipher Skin?
Founded in 2014, Cipher Skin specializes in the development of wearable medical devices that provide granular insights into human physiology. Unlike traditional tracking solutions, the company's technology captures complex movement and biometric data, offering a robust toolset for professionals in rehabilitation, recovery, and athletic performance. By transforming raw physical motion into actionable digital intelligence, Cipher Skin is effectively bridging the gap between subjective clinical observation and objective, data-driven health outcomes. Their market position is bolstered by a unique ability to synthesize multi-modal data, providing a holistic view of the human body in motion.
How much funding has Cipher Skin raised?
Cipher Skin has raised a total of $5M across 1 funding round:
Series A
$5M
Series A (2021): $5M with participation from TKC Capital, Boyett Group, Draper Capital, and Tribe Capital Growth Corp I
Key Investors in Cipher Skin
Tribe Capital Growth Corp I
A San Francisco-based investment firm focused on identifying and scaling high-growth technology companies through strategic business combinations and capital market expertise.
Draper Capital
A venture capital firm known for backing disruptive technologies and early-stage innovators across the global tech ecosystem.
TKC Capital
A private investment group providing strategic financial backing to emerging enterprises within the healthcare and technology sectors.
What's next for Cipher Skin?
With the successful closure of this major strategic investment, Cipher Skin is poised to transition from its current development phase into a period of aggressive commercial scaling. The company is expected to prioritize the expansion of its data infrastructure, further refining its algorithms to enhance the predictive capabilities of its biometric database. Strategic focus will likely shift toward deepening partnerships within the healthcare and sports science sectors, where the demand for precise, real-time physiological monitoring continues to rise. As the firm matures, the integration of its technology into standard clinical workflows will be a primary objective, ensuring that its data-centric approach becomes a cornerstone of modern recovery and performance optimization protocols.
See full Cipher Skin company page
